Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer. | Int Immunopharmacol | 2024 | 38552290 | PubTator, text mining | PubMed |
| Harnessing innate immune pathways for therapeutic advancement in cancer. | Signal Transduct Target Ther | 2024 | 38523155 | PubTator, text mining | PubMed |
| Label-free quantitative proteomics reveals the mechanisms of Aurora kinase B in renal cell carcinoma. | SAGE Open Med | 2024 | 38516642 | PubTator, text mining | PubMed |
| Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8+- and CD4+-cytotoxic T cells. | Immunology | 2024 | 38501302 | PubTator, text mining | PubMed |
| Causal relationship between immune cells and telomere length: mendelian randomization analysis. | BMC Immunol | 2024 | 38459464 | PubTator, text mining | PubMed |
| T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCC. | Blood | 2024 | 38457360 | PubTator, text mining | PubMed |
Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. | Int J Lab Hematol | 2024 | 38456256 | PubTator, text mining | PubMed |
| Identification of ANKRD13D as a potential target in renal cell carcinomas. | Int J Biol Markers | 2024 | 38449090 | PubTator, text mining | PubMed |
| Stable structures or PABP1 loading protects cellular and viral RNAs against ISG20-mediated decay. | Life Sci Alliance | 2024 | 38418089 | PubTator, text mining | PubMed |
| Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. | Leukemia | 2024 | 38409530 | PubTator, text mining | PubMed |
| Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs. | Pathogens | 2024 | 38392865 | PubTator, text mining | PubMed |
| Parameter-Efficient Fine-Tuning Enhances Adaptation of Single Cell Large Language Model for Cell Type Identification. | bioRxiv | 2024 | 38352605 | PubTator, text mining | PubMed |
| Construction and evaluation of immune-related diagnostic model in patients with heart failure caused by idiopathic dilated cardiomyopathy. | BMC Cardiovasc Disord | 2024 | 38321374 | PubTator, text mining | PubMed |
| Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer. | J Ovarian Res | 2024 | 38308314 | PubTator, text mining | PubMed |
| miR-Blood - a small RNA atlas of human blood components. | Sci Data | 2024 | 38307869 | PubTator, text mining | PubMed |
| G3BP1-dependent condensation of translationally inactive viral RNAs antagonizes infection. | Sci Adv | 2024 | 38295168 | PubTator, text mining | PubMed |
| RNA-seq analysis reveals modulation of inflammatory pathways by an enriched-triterpene natural extract in mouse and human macrophage cell lines. | Heliyon | 2024 | 38293365 | PubTator, text mining | PubMed |
| Decreased expression of TXNIP is associated with poor prognosis and immune infiltration in kidney renal clear cell carcinoma. | Oncol Lett | 2024 | 38288038 | PubTator, text mining | PubMed |
[The proportion of CD19+CD25+ Bregs in peripheral blood and the expression of PD-1 and PD-L1 on cell surface in patients with systemic lupus erythematosus and their correlation with clinical indicators]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2024 | 38284256 | PubTator, text mining | PubMed |
| COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study. | Blood Sci | 2024 | 38283406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=13